Is it time to Buy before this week’s earning report Integer (NYSE:ITGR)

Earnings results for Integer (NYSE:ITGR)

Integer Holdings Corporation is expected* to report earnings on 02/18/2021 before market open. The report will be for the fiscal Quarter ending Dec 2020. According to Zacks Investment Research, based on 1 analysts’ forecasts, the consensus EPS forecast for the quarter is $0.62. The reported EPS for the same quarter last year was $1.25.

Analyst Opinion on Integer (NYSE:ITGR)

4 Wall Street analysts have issued ratings and price targets for Integer in the last 12 months. Their average twelve-month price target is $99.33, predicting that the stock has a possible upside of 25.45%. The high price target for ITGR is $108.00 and the low price target for ITGR is $85.00. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus rating of “Buy.”

Integer has received a consensus rating of Buy. The company’s average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings. According to analysts’ consensus price target of $99.33, Integer has a forecasted upside of 25.5% from its current price of $79.18. Integer has received no research coverage in the past 90 days.

Dividend Strength: Integer (NYSE:ITGR)

Integer does not currently pay a dividend. Integer does not have a long track record of dividend growth.

Insiders buying/selling: Integer (NYSE:ITGR)

In the past three months, Integer insiders have not sold or bought any company stock. Only 2.19% of the stock of Integer is held by insiders. 96.46% of the stock of Integer is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Earnings and Valuation of Integer (NYSE:ITGR

Earnings for Integer are expected to grow by 33.83% in the coming year, from $2.69 to $3.60 per share. The P/E ratio of Integer is 35.99, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.51. The P/E ratio of Integer is 35.99, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 38.46. Integer has a P/B Ratio of 2.24. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

More latest stories: here